A panel discussion with AstraZeneca discussing how to simplify your data’s journey through a clean and simple data governance initiative - during uncertain times

• Changing environments and market drivers in COVID19 Era.
• Digital Engagement is the new Normal
• Foundational components of the Omni-Channel Strategy
• Methodology to Enable Seamless Omni Channel Experience

• De-silo your organizations data pools and connect them cross-functionally to empower your workforce with actionable insights
• Enable accurate product tracking by utilizing data feedback from across your organization
• Find a common platform across functions and prioritise use to create synergy
• Centralize data as your core decision mechanism to tailor growth strategies and gain a deeper understanding into your competitor landscape

• Identify digital engagement success and apply to strategies that will bring stakeholders across the ecosystem into one omni-channel driven campaign at the right time
• Provide a seamless connected journey in order to create long lasting connectivity between your organization, HCPs, and other stakeholders
• Cut through the noise and simplify digital communication with HCPs

As a Life Sciences company trying to best create accuracy and transparency in Gross-to-Net, you quickly learn that high risk is involved when discovering that a multitude of pricing scenarios is quickly mounting. Attempting to do this in as many as 25 spreadsheets linked together will render erroneous results. But there’s more to reaching the cornerstone of GTN than tools and technology.

• Defining what Gross-to-Net mean and why its important to Life Sciences companies
• Identify who in the company benefits in utilizing information from GTN
• Get insights to successfully define and manage GTN process

• Deliver a successful go-to-market strategy by redesigning your marketing and sales models to be consumer behaviour focused
• Equip field sales with real-time insights through live marketing feedback campaigns
• Remove power play behaviour between functions and implement common digital metrics to enable a collaborative revenue driven strategy

• With a shift in HCP preferences, expectations and a hybrid future, learn how to maximise your salesforce outputs by shifting the way your organization sets KPI’s as well as the metrics used to read them
• New methods to provide value to your HCPs in virtual calls
• Learn how to match HCP preferences with sales rep interactions to leave long-lasting impressions that lead to conversions
• How can we you empower the digital rep experience from a service orientation perspective?

• Learn how to build an enterprise digital governance framework from the ground up to better manage externally facing digital assets
• Understand the various approaches to global/enterprise-wide governance to regions, countries, products and brands

• Just like a cookie on the internet, post-initial connection, you need to remain with your HCP at every step along their journey – this is made easier through online feedback systems and surveys where we can identify preferences and deliver accordingly
• The adoption of digital tools vary much like the skill levels of a physician, it’s important to know this when designating digital touchpoints in your campaign, learn how to increase digital adoption to drive meaning in future HCP engagement
• Learn how to engage the right channels, rather than every channel
• Once you have a localized proof of concept, learn how to scale data tactics across national strategies to create hyper-personalized experiences

• Current state of HCP access post-COVID
• Do you have a clearly defined objective for virtual results?
• Critical considerations design and implementing your 2022 virtual HOP

• Centralize engagement activities on one platform and looping in all functions with marketing strategies to ensure everyone is on the same page
• Track engagement campaigns to bolster transparency and accountability across your entire organization
• Legacy platforms are stunting your ability to be agile in decision-making. How to analyse emerging technologies and platforms that will increase investment margins and break-down barriers between organization functions

• Data vs. Insights: why too much information could turn you idle, and enough insights make you stand from the crowd
• Learn how to sync channels and stories to personalise your customer journeys and be ready to scale
• Tame your marketing funnel: use data and insights to build dynamic acquisition and retention tactics, delivering measurable brands performance
• Understand how to structure your organisation, within and with external ecosystems, to be ready for a cookie-free experience

• Understand how omnichannel is much more than investing in cutting-edge technology and data
• Learn how omnichannel can drive one-customer-view by combining Medical and Marketing customer engagement
• See how a good omnichannel becomes great when the field-colleagues embrace it
• Best practices from scaling omnichannel design and implementation across 25+ global markets

• Treat data as an asset in its own right. Understand the journey it has been on and knowing your HCP strategic next best action will come naturally
• Remain agile and create various campaign roadmaps by learning how to rapidly interpret your data sets correctly
• Pick the right data points relevant to your brand strategy and marketing campaign to render a more rounded HCP impression

• Atone your data gaps to design acute product launches around HCP behavioural insights
• Understand what impression you have made, rather than if you made an impression – evolve from standard KPI’s to VoC (Voice of Customer) metrics by lining your product and strategy with trackable metrics from the outset
• Continuously identify new touchpoints and amend those that aren’t working by mapping your HCPs journey

• Discover how Eli Lilly employed a novel social media strategy to drive awareness of Medical information, Medical education and the latest scientific data.
• Reactive and proactive: raise HCP awareness at congresses while effectively navigating compliance requirements
• Use social listening to identify HCP conversation trends and provide the information that customers want

• Learn how to effectively and pragmatically use artificial AI to gain actionable Medical Insights from HCP interactions
• Beyond the buzz. Learn what works, what doesn’t work and how AI can help you deliver more informed actions from your Medical Insights analysis

This educational session is approved for 1 CME/CE credit(s) approved and accredited by the Accreditation Council for Medical Affairs (ACMA). To redeem your credit(s), register for Pharma USA 2022 today then apply for the credit via our event platform app.

• Empower your MSL team with specialized training to adopt the deep knowledge needed to enhance clinical practice in relation to their therapeutic area
• Enhance scientific exchange: Execute on an effective engagement plan that can enrich the generation and dissemination of evidence
• Learn from ASC Therapeutics on how they specialized their MSLs to interact with the right KOsL, extract meaningful insights and thus improve outcomes in the space of rare diseases

This educational session is approved for 1 CME/CE credit(s) approved and accredited by the Accreditation Council for Medical Affairs (ACMA). To redeem your credit(s), register for Pharma USA 2022 today then apply for the credit via our event platform app.

• Generate an effective omni-channel strategy that can enable enhanced, evidence-based decision making
• Your closed-feedback loop: Deliver actionable insights from every engagement point to further optimize physician experience and enhance their interactions with patients
• Next generation engagement: utilize your strategy to deliver personalized content to the right stakeholders going forward
• How to navigate global and local restrictions to deliver industry leading omni-channel excellence

• Learn what the leading benchmark data reveals about what are the most critical KPIs across the industry in medical affairs.
• Compare and contrast various professional development frameworks for medical affairs
• Explore the role of Board certification for Medical Affairs and MSL professionals as a road map for continuing development and standards setting.

• Understand how the core medical roles are changing going forward and how this will impact wider external engagement strategy across the business
• Driving value: A guide to the essential skills MSLs must have to stand out to physicians
• Learn from AstraZeneca as they reimagine their medical roles to optimize insights, diversify clinical trials and create value for patients

• The right channels, the right time: Learn how Pfizer first gained clear understanding of their audience segments to enable dynamic content provision
• Understand how to incorporate the value of storytelling in the ways you communicate, to prevent physicians from feeling “zoomed out” and develop long-lasting relationships

• Understand how digital advancements have impacted the role of MSLs and what new competencies are now required to keep up with the competitive landscape
• Utilize digital resources to best train your Field Medical team on how to personalize HCP engagement strategies and approach the next generation of physicians and researchers
• Drive a digital culture change: Upskill and retrain your MSLs for emerging digital roles and responsibilities to optimize insight generation and maximize the value of Medical Affairs

• Support the growing visibility of underrepresented groups in healthcare by investing in programs that encourage diverse leadership in patient advocacy and among HCPs
• Acknowledge and address historical mistrust of pharma among minority patient groups by championing diverse voices within
• Prioritize an inside-out approach by tackling internal unconscious biases in hiring practices, and ensure patient teams and stakeholders are diverse across the value chain

• Respond to new patient openness towards working with pharma and create critical opportunities for patients to collaborate across the value chain
• Learn how to embed the patient voice in key workstreams through long-term and proactive co-creation strategies
• Establish iterative feedback processes to ensure that company strategy adapts to changes in patient needs and delivers real value to communities

• Learn how the COVID vaccine race has transformed the way patients now engage with pharma brands
• Discover how COVID vaccine misinformation has reshaped patient perceptions of pharma brands, and what you can do about it
• Find out which patient segments are most/least engaged with pharma information
• Hear what patients of color want to see Pharma brands do to address healthcare inequities
• See the ways HCPs are adapting to more empowered patients and how pharma brands can play a role

• Patients have never been more autonomous and hold unprecedented power as an industry stakeholder, while navigating health information online is more precarious than ever before
• Review the impact of shifts in the pharma-patient dynamic and the increasing role of patient/industry collaboration on the wider healthcare continuum
• Empower diverse patient groups with a contextualized approach to engagement that takes social determinants of health and historic distrust of medical authority into account
• Prioritize partnerships with minority HCP and patient leaders to ensure accurate information is front and center for all patient demographics

• Harness digital data held by non-dispensing online pharmacies to better understand the patient prescription journey
• Gain real-time insights on why patients are or aren’t adhering to therapies, and the prevalence of adherence barriers faced by patients
• Redefine patient support services and develop targeted strategies that can successfully intervene to ensure adherence is upheld

• Learn how pharma is adopting AI technologies to revolutionize patient engagement
• Identify key use cases for AI to provide more personalized and targeted patient engagement
• Explore the future role of AI in advancing patient engagement

• Explore strategies around re-designing your current PSP programs, including establishing strategic imperatives, organizational re-design, and updating business rules
• Share insights around operationalizing your strategy, and the impact of this on the business and your stakeholders
• Create digitally inspired channels to personalize HCP and patient engagement that delivers on the unmet needs of your customers/li>

• Understand what digital equity and accessibility is and why it is so important for the future of patient-centric practice
• Learn how task forces comprising stakeholders from pharma, big tech and health bodies (including WHO) are convening to address the impact of digital inaccessibility on health outcomes
• See how adjustments to your customer-facing digital touchpoints can increase access and engagement for patients and other stakeholder groups across the business

• Improve patient enrollment by finding the most important points in provider and patient journeys for new service initiatives
• Ensure your service’s target and solve real-world patient unmet needs, not just business needs, through a complete understanding of patient pain points
• Break current boundaries and Rethink the possibilities to improve key concerns within the journey that unleash new opportunities

• Data trends: Key stats on health plan premiums, deductibles, co-insurance and patient access
• Scientific Analysis: Research on the relationships between patient cost-sharing, adherence and health outcomes
• Affordable Access: Understanding patient out-of-pocket costs, causes and consequences
• Paths Forward: Aligning all stakeholders around clinically-driven payment reform and value-based insurance designs

• Current state of clinical research is still heavily dependent on manual and duplicative data collection process while the value of EHRs have not yet been leveraged
• Investing in digital innovations like EHR-EDC can lead to faster approval, reduced patient and researcher burden and innovative evidence generation

• How to understand what data payers are looking for, and what they should be looking at, in submissions for first-to-market therapies
• Payers want a ‘willing participant in negotiating an optimal contract’ – a discussion into value, outcomes, and discount-based contracts that meet payer needs and increase access
• Educate payers on the scientific and economic value props of your therapy to help them better understand long-term value of approving access

• Navigate through unstructured data and free text to your 'needle in the haystack', using AI technology and machine learning analysis methods
• Expand data science capabilities internally to source meaningful evidence from large RWD sets and translate it across the company
• Work smart with data providers to navigate and narrow down large data sets, while also exploring new data channels

• Leverage real-world data to generate evidence around comparative effectiveness, including RWE methods and reducing bias
• Understand special considerations when using RWD for CER for regulators
• Examine case examples of how large real-world datasets can generate more powerful comparative effectiveness insights

• Identify the crucial real-world evidence needed during the different stages of product development for awareness of disease burden and product approval
• Maximise the value of Field Medical: Reveal the ultimate RWE and Medical collaboration to effectively generate actionable insights and documented evidence for product launch
• Understand how MSLs can champion their deep understanding of science to become the main coordinators of information, not just on post-approval stages but earlier on in the product lifecycle
• Successfully identify the right physicians to participate in studies through leveraging your Field team relationships and in turn enhance patient outcomes

Identifying and reaping the benefits from AI and real-word data (RWD) tools can prove difficult in the marketing function. Understanding how to apply RWD and artificial intelligence to the patient care and HCP journey is key to overcoming this challenge.

Join this collaborative, 60-minute workshop, where you’ll learn:

• How to target brand engagement through AI tools and real-world data
• The “difference-maker” use cases where AI and real-world data have the most impact
• How to give your brand a competitive advantage by anchoring your AI strategy in the patient care journey
• A practical approach for analyzing your brand journey and developing an AI strategy

Lead and Sponsored by OptimizeRX

• Adapt to shifting patient needs and empower people to take control of their health journeys
• Shape the future of healthcare, disease prevention, and patient support
• Increase your reach and maximize impact with RWD-driven insights to improve long-term outcomes

Don’t get left behind - Behavioral Science is fast becoming a foundational tool in the expert marketers’ toolbox, not only in pharma but in global organizations across industries.

This session will give you the knowledge and skills to help you stay at the cutting edge to remain competitive and impactful, no matter if your target audience is patients or HCPs (we’re all human, after all).

You will:

• Learn what behavioral science is – no previous knowledge required!
• Understand how behavioral science can be used in the pharma space through case studies and examples
• Get hands-on practice in creating your own “nudges,” or behavioral science solutions, so you can walk away ready to apply the tools to your own work

We believe pharma companies’ impact on society is more than just shareholder value, revenues, and profits. It’s time we explore and understand the importance of SI as part of ESG reporting. In this 60 minute, interactive workshop you’ll learn about Societal Impact (SI) as a concept plus:

•  Discuss the leading frameworks to capture SI (Harvard Business School, WifOR, and others)
• Brainstorm and evaluate which factors we must cover to quantify SI (health benefits, productivity gains, associated averted costs, community spillovers, and many more…)
• Get stuck in: With no established standard, let’s push the boundaries of what’s possible in SI!

Lead and Sponsored by Campana & Schott

• Personalization that accelerates engagement
• Using content to help turn patients into advocates
• Putting data to work to enhance the patient experience

Lead and Sponsored by Harte Hanks